These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21094816)
1. Hyperuricemia in kidney transplant recipients with intact graft function. Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816 [TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia in adult renal allograft recipients: prevalence and predictors. Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595 [TBL] [Abstract][Full Text] [Related]
3. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia. Einollahi B; Einollahi H; Rostami Z Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044 [TBL] [Abstract][Full Text] [Related]
4. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation. Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221 [TBL] [Abstract][Full Text] [Related]
5. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747 [TBL] [Abstract][Full Text] [Related]
6. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease. Satirapoj B; Supasyndh O; Nata N; Phulsuksombuti D; Utennam D; Kanjanakul I; Choovichian P; Duangurai K J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S65-70. PubMed ID: 21280518 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of early-onset hyperuricemia in renal transplant recipients. Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570 [TBL] [Abstract][Full Text] [Related]
8. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients. Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study. Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377 [TBL] [Abstract][Full Text] [Related]
10. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726 [TBL] [Abstract][Full Text] [Related]
11. Effects of hyperuricemia on renal function in pediatric renal transplant recipients. Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164 [TBL] [Abstract][Full Text] [Related]
12. Association of serum phosphorus level with anemia in kidney transplant recipients. Kovesdy CP; Mucsi I; Czira ME; Rudas A; Ujszaszi A; Rosivall L; Kim SJ; Wolf M; Molnar MZ Transplantation; 2011 Apr; 91(8):875-82. PubMed ID: 21358369 [TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Akalin E; Ganeshan SV; Winston J; Muntner P Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445 [TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Karbowska A; Boratynska M; Kusztal M; Klinger M Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674 [TBL] [Abstract][Full Text] [Related]
15. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754 [TBL] [Abstract][Full Text] [Related]
16. Role of uric acid in post-renal transplantation hypertension. Bandukwala F; Huang M; Prasad GV Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696 [TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291 [TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia in pediatric renal transplant recipients. Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940 [TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions. Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822 [TBL] [Abstract][Full Text] [Related]